{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:53:45Z","timestamp":1740164025913,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty Foundation","doi-asserted-by":"publisher","award":["YF 2020-YF0056"],"award-info":[{"award-number":["YF 2020-YF0056"]}],"id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Inga-Britt and Arne Lundberg\u2019s Research Foundation"},{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous in vivo studies on the ketogenic diet, a diet that can induce metabolic conditions resembling those following extended starvation, demonstrate strong outcomes on cancer survival, particularly when combined with chemo-, radio- or immunological treatments. However, the therapeutic application of ketogenic diets requires strict dietary adherence from well-informed and motivated patients, and it has recently been proposed that hemodialysis might be utilized to boost ketosis and further destabilize the environment for cancer cells. Yet, plasma ketones may be lost in the dialysate\u2014lowering blood ketone levels. Here we performed a single 180-min experimental hemodialysis (HD) session in six anesthetized Sprague\u2013Dawley rats given ketogenic diet for five days. Median blood ketone levels pre-dialysis were 3.5\u00a0mmol\/L (IQR 2.2 to 5.6) and 3.8\u00a0mmol\/L (IQR 2.2 to 5.1) after 180\u00a0min HD, <jats:italic>p<\/jats:italic>\u2009=\u20090.54 (95% CI \u2212\u00a00.6 to 1.2). Plasma glucose levels were reduced by 36% (\u2212\u00a04.5\u00a0mmol\/L), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 (95% CI \u2212\u00a06.7 to \u2212\u00a02.5). Standard base excess was increased from \u2212\u00a03.5\u00a0mmol\/L (IQR \u2212\u00a04 to \u2212\u00a02) to 0.5\u00a0mmol\/L (IQR \u2212\u00a01 to 3), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 (95% CI 2.0 to 5.0). A theoretical model was applied confirming that intra-dialytic glucose levels decrease, and ketone levels slightly increase since hepatic ketone production far exceeds dialytic removal. Our experimental data and <jats:italic>in-silico<\/jats:italic> modeling indicate that elevated blood ketone levels during ketosis are maintained during hemodialysis despite dialytic removal.<\/jats:p>","DOI":"10.1038\/s41598-023-46715-7","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:02:38Z","timestamp":1699527758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experimental hemodialysis in diet-induced ketosis and the potential use of dialysis as an adjuvant cancer treatment"],"prefix":"10.1038","volume":"13","author":[{"given":"Carl M.","family":"\u00d6berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sternby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Storr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Flieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Harenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"K\u00e4llquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sture","family":"Hobro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"46715_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi, C. & Lippi, G. Current cancer epidemiology. J. Epidemiol. Glob. Health 9, 217\u2013222. https:\/\/doi.org\/10.2991\/jegh.k.191008.001 (2019).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"46715_CR2","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.3390\/cancers14205054","volume":"14","author":"S Hobro","year":"2022","unstructured":"Hobro, S. et al. Dialysis as a novel adjuvant treatment for malignant cancers. Cancers 14, 5054 (2022).","journal-title":"Cancers"},{"key":"46715_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber, D. D. et al. Ketogenic diet in the treatment of cancer: Where do we stand?. Mol. Metab. 33, 102\u2013121. https:\/\/doi.org\/10.1016\/j.molmet.2019.06.026 (2020).","journal-title":"Mol. Metab."},{"key":"46715_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1744-9987.2007.00491.x","volume":"11","author":"M Abe","year":"2007","unstructured":"Abe, M., Kaizu, K. & Matsumoto, K. Plasma insulin is removed by hemodialysis: Evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose. Ther. Apher. Dial. 11, 280\u2013287 (2007).","journal-title":"Ther. Apher. Dial."},{"key":"46715_CR5","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/ajcn\/31.10.1870","volume":"31","author":"RL Wathen","year":"1978","unstructured":"Wathen, R. L., Keshaviah, P., Hommeyer, P., Cadwell, K. & Comty, C. M. The metabolic effects of hemodialysis with and without glucose in the dialysate. Am. J. Clin. Nutr. 31, 1870\u20131875. https:\/\/doi.org\/10.1093\/ajcn\/31.10.1870 (1978).","journal-title":"Am. J. Clin. Nutr."},{"key":"46715_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.memsci.2012.03.001","volume":"413","author":"J Axelsson","year":"2012","unstructured":"Axelsson, J., \u00d6berg, C. M., Rippe, A., Krause, B. & Rippe, B. Size-selectivity of a synthetic high-flux and a high cut-off dialyzing membrane compared to that of the rat glomerular filtration barrier. J. Membr. Sci. 413, 29\u201337 (2012).","journal-title":"J. Membr. Sci."},{"key":"46715_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/sdi.12534","volume":"29","author":"B Rippe","year":"2016","unstructured":"Rippe, B. & Oberg, C. M. Albumin turnover in peritoneal and hemodialysis. Semin. Dial. 29, 458\u2013462. https:\/\/doi.org\/10.1111\/sdi.12534 (2016).","journal-title":"Semin. Dial."},{"key":"46715_CR8","unstructured":"Todd, A. J. Inclusion of a Glycogen Regulation Mathematical Model into a Contextual Metabolic Framework (The University of North Carolina at Chapel Hill, 2008)."},{"key":"46715_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002272","volume":"7","author":"K Xu","year":"2011","unstructured":"Xu, K., Morgan, K. T., Todd Gehris, A., Elston, T. C. & Gomez, S. M. A whole-body model for glycogen regulation reveals a critical role for substrate cycling in maintaining blood glucose homeostasis. PLoS Comput. Biol. 7, e1002272. https:\/\/doi.org\/10.1371\/journal.pcbi.1002272 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"46715_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/clinchem\/44.3.655","volume":"44","author":"N Fogh-Andersen","year":"1998","unstructured":"Fogh-Andersen, N. & D\u2019Orazio, P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin. Chem. 44, 655\u2013659 (1998).","journal-title":"Clin. Chem."},{"key":"46715_CR11","first-page":"114","volume":"12","author":"N Fogh-Andersen","year":"2000","unstructured":"Fogh-Andersen, N. et al. Recommendation on reporting results for blood glucose (from an IFCC stage 1 document) IFCC scientific division working group on selective electrodes. EJIFCC 12, 114\u2013116 (2000).","journal-title":"EJIFCC"},{"key":"46715_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MAT.0b013e3182452b57","volume":"58","author":"D Schneditz","year":"2012","unstructured":"Schneditz, D., Zierler, E., Martinelli, E., Czabak-Garbacz, R. & Hoehlein, M. Clearance, distribution volume, and dialyzer mass area transport coefficient of glucose in whole blood. ASAIO J. 58, 137\u2013142. https:\/\/doi.org\/10.1097\/MAT.0b013e3182452b57 (2012).","journal-title":"ASAIO J."},{"key":"46715_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233925","volume":"15","author":"M Fukunaga","year":"2020","unstructured":"Fukunaga, M. et al. In vivo evaluation of drug dialyzability in a rat model of hemodialysis. PLoS ONE 15, e0233925. https:\/\/doi.org\/10.1371\/journal.pone.0233925 (2020).","journal-title":"PLoS ONE"},{"key":"46715_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/08968608211069224","volume":"43","author":"J Helman","year":"2022","unstructured":"Helman, J. & \u00d6berg, C. M. High versus low ultrafiltration rates during experimental peritoneal dialysis in rats: Acute effects on plasma volume and systemic haemodynamics. Perit. Dial. Int. 43, 84\u201391. https:\/\/doi.org\/10.1177\/08968608211069224 (2022).","journal-title":"Perit. Dial. Int."},{"key":"46715_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.rvsc.2016.06.012","volume":"107","author":"GS Zhang","year":"2016","unstructured":"Zhang, G. S. et al. Dairy cows affected by ketosis show alterations in innate immunity and lipid and carbohydrate metabolism during the dry off period and postpartum. Res. Vet. Sci. 107, 246\u2013256. https:\/\/doi.org\/10.1016\/j.rvsc.2016.06.012 (2016).","journal-title":"Res. Vet. Sci."},{"key":"46715_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ckj\/sfu026","volume":"7","author":"J Apel","year":"2014","unstructured":"Apel, J., Reutrakul, S. & Baldwin, D. Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease. Clin. Kidney J. 7, 248\u2013250. https:\/\/doi.org\/10.1093\/ckj\/sfu026 (2014).","journal-title":"Clin. Kidney J."},{"key":"46715_CR17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00424-022-02718-3","volume":"474","author":"AA McDonough","year":"2022","unstructured":"McDonough, A. A. & Fenton, R. A. Potassium homeostasis: Sensors, mediators, and targets. Pflugers Arch. 474, 853\u2013867. https:\/\/doi.org\/10.1007\/s00424-022-02718-3 (2022).","journal-title":"Pflugers Arch."},{"key":"46715_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1096\/fasebj.27.1_supplement.794.2","volume":"27","author":"J Meidenbauer","year":"2013","unstructured":"Meidenbauer, J., Ta, N. & Seyfried, T. Influence of dietary intake on plasma metabolites and lipids in C57BL\/6J mice. Faseb J. 27, 794 (2013).","journal-title":"Faseb J."},{"key":"46715_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI107839","volume":"54","author":"AJ Garber","year":"1974","unstructured":"Garber, A. J., Menzel, P. H., Boden, G. & Owen, O. E. Hepatic ketogenesis and gluconeogenesis in humans. J. Clin. Invest. 54, 981\u2013989. https:\/\/doi.org\/10.1172\/JCI107839 (1974).","journal-title":"J. Clin. Invest."},{"key":"46715_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0026-0495(79)90166-5","volume":"28","author":"EO Balasse","year":"1979","unstructured":"Balasse, E. O. Kinetics of ketone body metabolism in fasting humans. Metabolism 28, 41\u201350. https:\/\/doi.org\/10.1016\/0026-0495(79)90166-5 (1979).","journal-title":"Metabolism"},{"key":"46715_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1432-1033.1984.tb08240.x","volume":"141","author":"HJ Balks","year":"1984","unstructured":"Balks, H. J. & Jungermann, K. Regulation of peripheral insulin\/glucagon levels by rat liver. Eur. J. Biochem. 141, 645\u2013650. https:\/\/doi.org\/10.1111\/j.1432-1033.1984.tb08240.x (1984).","journal-title":"Eur. J. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46715-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46715-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46715-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:11:00Z","timestamp":1699528260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46715-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46715"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46715-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M. \u00d6berg reports research grants from Baxter Healthcare and Fresenius Medical Care, and speaker\u2019s honoraria from Baxter Healthcare. C.M. \u00d6berg reports a consultancy agreement with Baxter Healthcare and an advisory or leadership role with the Peritoneal Dialysis International editorial board. All other authors are employees of Baxter Healthcare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19476"}}